Cefazolin and Iron dextran drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Iron dextran (iron dextran). Common drug interactions include blood bilirubin increased among females and blood parathyroid hormone increased among males.
The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Iron dextran. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Cefazolin?
Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.
What is Iron dextran?
Iron dextran has active ingredients of iron dextran. It is often used in anemia. eHealthMe is studying from 1,487 Iron dextran users. Check the latest studies of Iron dextran.
13 people who take Cefazolin and Iron dextran together, and have interactions are studied.

What are the common drug interactions of Cefazolin and Iron Dextran, by gender? *:
female:
- Blood bilirubin increased
- Blood creatinine increased
- Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
- Cerebral haemorrhage (bleeding within the brain)
- Confusional state
- Haemoglobin decreased
- Hypotension (abnormally low blood pressure)
- Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
- Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
- Subdural haematoma (blood collects between the skull and the surface of the brain)
male:
- Blood parathyroid hormone increased
- Alanine aminotransferase increased
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anti-erythropoietin antibody positive
- Anxiety
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Back pain
- Blood alkaline phosphatase increased
- Blood potassium decreased
- Body temperature increased
What are the common drug interactions of Cefazolin and Iron Dextran, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Back pain
- Blood bilirubin increased
- Blood creatinine increased
- Brain herniation (brain herniation is a potentially deadly side effect of very high intracranial pressure that occurs when a part of the brain is squeezed across structures within the skull)
- Cerebral haemorrhage (bleeding within the brain)
- Chest pain
- Confusional state
- Haemoglobin decreased
- Hypotension (abnormally low blood pressure)
- Infusion related reaction
60+:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood alkaline phosphatase increased
- Blood potassium decreased
- Body temperature increased
- Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
- C-reactive protein increased
- Cardiac enzymes increased
- Cerebral infarction (less blood supply to brain resulting tissue damage)
What are the existing conditions these people have? *
- Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 5 people, 38.46%
- Anaemia (lack of blood): 2 people, 15.38%
- Tenderness (pain or discomfort when an affected area is touched): 1 person, 7.69%
- Swelling: 1 person, 7.69%
- Pain: 1 person, 7.69%
- Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 1 person, 7.69%
- Iron Deficiency Anaemia: 1 person, 7.69%
- Hypotension (abnormally low blood pressure): 1 person, 7.69%
- Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 7.69%
- Chronic Renal Failure (kidney failure): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Cefazolin and Iron dextran?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cefazolin (15,157 reports)
- Iron dextran (1,487 reports)
Browse all drug interactions of Cefazolin and Iron dextran:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Iron dextran:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Iron dextran and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium and iron dextran (the active ingredients of Cefazolin and Iron dextran, respectively), and Cefazolin and Iron dextran (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Zinacef cause Gums - Swollen? - 8 seconds ago
- Drug interactions of Xyrem and Hydrocodone Bitartrate - 15 seconds ago
- Drug interactions of Lotrel and Acetaminophen - 15 seconds ago
- Selenium vs. Vitamin B6, side effect and effectiveness comparison - 17 seconds ago
- Could Fish Oil cause Leukopenia? - 19 seconds ago
- Drug interactions of Teriflunomide and Amantadine - 33 seconds ago
- Drug interactions of Isoniazid and Valcyte - 33 seconds ago
- Could Marcaine cause Heart Attack? - 36 seconds ago
- Could Mucinex Dm cause Hoarseness Or Changing Voice? - 52 seconds ago
- Could Temaz cause Excessive Or Unwanted Hair In Women? - 54 seconds ago